Published in J Environ Public Health on December 15, 2011
Detection of mycotoxins in patients with chronic fatigue syndrome. Toxins (Basel) (2013) 2.88
A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal (2013) 0.88
A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis. J Environ Public Health (2011) 0.80
Chronic illness associated with mold and mycotoxins: is naso-sinus fungal biofilm the culprit? Toxins (Basel) (2013) 0.79
An Evolutionary-Based Framework for Analyzing Mold and Dampness-Associated Symptoms in DMHS. Front Immunol (2017) 0.75
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis (2001) 4.06
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology (2001) 3.20
Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol (2005) 2.47
Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect (2011) 1.89
Public health and economic impact of dampness and mold. Indoor Air (2007) 1.79
JEM Spotlight: Fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors from water-damaged buildings. J Environ Monit (2009) 1.62
Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health (2009) 1.56
Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope (2009) 1.54
Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol (2005) 1.22
The mitochondrial toxin produced by Streptomyces griseus strains isolated from an indoor environment is valinomycin. Appl Environ Microbiol (1998) 1.20
CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc (2007) 1.19
Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique. Thorax (1998) 1.18
Invasive Streptomyces infections: six cases and literature review. Am J Clin Pathol (2007) 1.17
Association of residential dampness and mold with respiratory tract infections and bronchitis: a meta-analysis. Environ Health (2010) 1.12
Fungal Fragments in Moldy Houses: A Field Study in Homes in New Orleans and Southern Ohio. Atmos Environ (1994) (2007) 1.04
Filamentous microorganisms and their fragments in indoor air--a review. Ann Agric Environ Med (2004) 1.01
Novel metabolites from Penicillium crustosum, including penitrem E, a tremorgenic mycotoxin. Appl Environ Microbiol (1981) 1.01
Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch Environ Health (2003) 0.96
Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments. Indoor Air (2011) 0.96
Endotoxin and occupational airway disease. Curr Opin Allergy Clin Immunol (2006) 0.95
The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes. Toxicol Ind Health (2009) 0.95
Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics and potentiation by bacterial lipopolysaccharide coexposure. Toxicol Sci (2007) 0.94
Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem Res Toxicol (2007) 0.94
Mold exposure and respiratory health in damp indoor environments. Front Biosci (Elite Ed) (2011) 0.94
Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells. BMC Microbiol (2007) 0.93
Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol Sci (2011) 0.92
Mycotoxin detection in human samples from patients exposed to environmental molds. Int J Mol Sci (2009) 0.92
Neurobehavioral and pulmonary impairment in 105 adults with indoor exposure to molds compared to 100 exposed to chemicals. Toxicol Ind Health (2009) 0.91
Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarum. Environ Health Perspect (2004) 0.90
Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments. Arch Environ Health (2004) 0.88
Molds and mycotoxins in indoor environments--a survey in water-damaged buildings. J Occup Environ Hyg (2009) 0.87
The treatment of patients with mycotoxin-induced disease. Toxicol Ind Health (2009) 0.84
Maxillary sinuses microbiology from patients with chronic rhinosinusitis. Braz J Otorhinolaryngol (2010) 0.84
Role of molds and mycotoxins in being sick in buildings: neurobehavioral and pulmonary impairment. Adv Appl Microbiol (2004) 0.83
Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study. BMC Nephrol (2009) 0.83
Chronic sinusitis: defective T-cells responding to superantigens, treated by reduction of fungi in the nose and air. Arch Environ Health (2003) 0.83
The possible role of fungal contamination in sick building syndrome. Front Biosci (Elite Ed) (2011) 0.83
Fungal exposure endocrinopathy in sinusitis with growth hormone deficiency: Dennis-Robertson syndrome. Toxicol Ind Health (2009) 0.82
Endoscopically guided aerobic cultures in postsurgical patients with chronic rhinosinusitis. Am J Rhinol (2006) 0.81
MS/MS screen for the tremorgenic mycotoxins roquefortine and penitrem A. J Vet Diagn Invest (1996) 0.80
Do terbutaline- and mold-associated impairments of the brain and lung relate to autism? Toxicol Ind Health (2009) 0.79
Verruculogen production in airborne and clinical isolates of Aspergillus fumigatus Fres. Acta Pharm (2005) 0.78
Causes of fever in adults on the Thai-Myanmar border. Am J Trop Med Hyg (2006) 2.17
Latrodectism: a prospective cohort study of bites by formally identified redback spiders. Med J Aust (2003) 1.61
White-tail spider bite: a prospective study of 130 definite bites by Lampona species. Med J Aust (2003) 1.50
Nondisclosure of conflicts of interest is perilous to the advancement of science. J Allergy Clin Immunol (2006) 1.37
Leptospirosis in Kamphaeng Phet, Thailand. Am J Trop Med Hyg (2007) 0.95
Mold and mycotoxins: effects on the neurological and immune systems in humans. Adv Appl Microbiol (2004) 0.91
Low-level hydrogen sulfide and central nervous system dysfunction. Toxicol Ind Health (2010) 0.90
Bites by spiders of the family Theraphosidae in humans and canines. Toxicon (2003) 0.83
Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Arch Environ Health (2003) 0.82
Use of patient-specific Leptospira isolates in the diagnosis of leptospirosis employing microscopic agglutination testing (MAT). Trans R Soc Trop Med Hyg (2011) 0.82
Isolation of sulfur reducing and oxidizing bacteria found in contaminated drywall. Int J Mol Sci (2010) 0.81
Antibodies to molds and satratoxin in individuals exposed in water-damaged buildings. Arch Environ Health (2003) 0.78
Effects of envenoming by comb-footed spiders of the genera Steatoda and Achaearanea (family Theridiidae: Araneae) in Australia. J Toxicol Clin Toxicol (2003) 0.77
Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings. Arch Environ Health (2003) 0.77
Summary of the 5th International Conference on Bioaerosols, Fungi, Bacteria, Mycotoxins, and Human Health. Arch Environ Health (2003) 0.76
Funnel-web spider bite: a systematic review of recorded clinical cases. Med J Aust (2005) 0.76
Why is chemical brain injury ignored? Pondering causes and risks. Arch Environ Health (2003) 0.75
Janus revisited, molds again. Arch Environ Health (2002) 0.75
Mold and mycotoxin symposium: towards healthy homes. Toxicol Ind Health (2009) 0.75
Towards healthy homes. Toxicol Ind Health (2009) 0.75
Stop inhaling smoke: prevent coronary heart disease. Arch Environ Health (2003) 0.75